QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
QL01FY Combinations of monoclonal antibodies and antibody drug conjugates
QL01FY01 pertuzumab and trastuzumab
QL01FY02 nivolumab and relatlimab
QL01FY03 prolgolimab and nurulimab
Last updated: 2024-01-17